Genprex, Inc.
GNPX
$0.1727
$0.00321.89%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -55.00% | -47.45% | -33.52% | -50.54% | 19.53% |
| Depreciation & Amortization | -- | -- | -85.29% | -64.86% | -39.47% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -28.17% | -33.81% | -27.35% | -44.47% | -18.91% |
| Operating Income | 28.17% | 33.81% | 27.35% | 44.47% | 18.91% |
| Income Before Tax | 28.03% | 33.58% | 22.29% | 44.30% | 18.60% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 28.03% | 33.58% | 22.29% | 44.30% | 18.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 28.03% | 33.58% | 22.29% | 44.30% | 18.60% |
| EBIT | 28.17% | 33.81% | 27.35% | 44.47% | 18.91% |
| EBITDA | 28.18% | 33.81% | 27.32% | 44.46% | 18.90% |
| EPS Basic | 94.36% | 93.27% | 86.76% | 77.00% | 51.07% |
| Normalized Basic EPS | 94.36% | 92.96% | 87.56% | 77.00% | 51.07% |
| EPS Diluted | 94.36% | 93.27% | 86.76% | 77.00% | 51.07% |
| Normalized Diluted EPS | 94.36% | 92.96% | 87.56% | 77.00% | 51.07% |
| Average Basic Shares Outstanding | 1,176.32% | 843.35% | 486.94% | 142.17% | 66.37% |
| Average Diluted Shares Outstanding | 1,176.32% | 843.35% | 486.94% | 142.17% | 66.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |